Skip to main content
. 2022 Jan;11(1):138–148. doi: 10.21037/tp-21-595

Table 2. Efficacy of refractory epilepsy in the ketogenic group.

Therapeutic time (months) Total cases Valid cases (%) Invalid cases (%)
Grade I (%) Grade I, II and III Effective rate (%)
3 102 61 (59.80) 20 81 (79.41) 21 (20.59)
6 98 56 (57.14) 22 78 (79.59) 20 (20.41)
9 95 53 (55.79) 24 77 (81.05) 18 (18.95)
12 90 48 (53.33) 25 73 (81.11) 17 (18.89)
18 87 49 (56.32) 18 67 (77.01) 20 (22.99)
24 80 43 (53.75) 20 63 (78.75) 17 (21.25)